Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- New System Automatically Prepares Tissue Sections: Kurabo
September 18, 2006
- Direct Price Bargaining between Makers and Med. Institutions
September 18, 2006
- MEDICAL DEVICE NEWS IN BRIEF
September 18, 2006
- Industry, JPA Oppose Korosho's Discussion Proposal on NHI Pricing and Revision Frequency
September 18, 2006
- NEW PRODUCTS
September 18, 2006
- Key Points of Discussion on the NHI Pricing Criteria and the Frequency of NHI Price Revisions
September 18, 2006
- Towa Pharmaceutical Begins Business with Suzuken Nationwide
September 18, 2006
- Chuikyo Approves NHI Price Listing of 13 API/20 Products
September 18, 2006
- Errorneous Medical Bills Remain at High Levels
September 18, 2006
- Asahi Kasei Files for ART-123 in Japan, Licenses It to Artisan Pharma Overseas
September 18, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 18, 2006
- Korosho Calls For Tax Break for Unapproved Drugs, Bio-hazard Measures
September 18, 2006
- Eisai Acquires 4 Oncology Products from Ligand
September 18, 2006
- REGULATORY NEWS IN BRIEF
September 18, 2006
- MEETING 65th JCA Annual Meeting to Be Held Sept. 28-30
September 18, 2006
- METI's Draft Budget Request Earmarks \2.8 Bil. for Anticancer Measures
September 11, 2006
- Working Team Proposes 5 New Targets for Healthy Japan 21 Project
September 11, 2006
- CDFS Committee Recommends Approval of 4 Drugs Including Velcade
September 11, 2006
- Weight of Healthcare Business Continues to Increase at Philips
September 11, 2006
- Group to Review Reports on Drugs for Pediatric Use
September 11, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…